1
|
ten Hove M, Smyris A, Booijink R, Wachsmuth L, Hansen U, Alic L, Faber C, Hӧltke C, Bansal R. Engineered SPIONs functionalized with endothelin a receptor antagonist ameliorate liver fibrosis by inhibiting hepatic stellate cell activation. Bioact Mater 2024; 39:406-426. [PMID: 38855059 PMCID: PMC11157122 DOI: 10.1016/j.bioactmat.2024.05.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2023] [Revised: 05/16/2024] [Accepted: 05/17/2024] [Indexed: 06/11/2024] Open
Abstract
Endothelin-1/endothelin A receptor (ET-1/ETAR) pathway plays an important role in the progression of liver fibrosis by activating hepatic stellate cells (HSCs) - a key cell type involved in the pathogenesis of liver fibrosis. Inactivating HSCs by blocking the ET-1/ETAR pathway using a selective ETAR antagonist (ERA) represents a promising therapeutic approach for liver fibrosis. Unfortunately, small-molecule ERAs possess limited clinical potential due to poor bioavailability, short half-life, and rapid renal clearance. To improve the clinical applicability, we conjugated ERA to superparamagnetic iron-oxide nanoparticles (SPIONs) and investigated the therapeutic efficacy of ERA and ERA-SPIONs in vitro and in vivo and analyzed liver uptake by in vivo and ex vivo magnetic resonance imaging (MRI), HSCs-specific localization, and ET-1/ETAR-pathway antagonism in vivo. In murine and human liver fibrosis/cirrhosis, we observed overexpression of ET-1 and ETAR that correlated with HSC activation, and HSC-specific localization of ETAR. ERA and successfully synthesized ERA-SPIONs demonstrated significant attenuation in TGFβ-induced HSC activation, ECM production, migration, and contractility. In an acute CCl4-induced liver fibrosis mouse model, ERA-SPIONs exhibited higher liver uptake, HSC-specific localization, and ET-1/ETAR pathway antagonism. This resulted in significantly reduced liver-to-body weight ratio, plasma ALT levels, and α-SMA and collagen-I expression, indicating attenuation of liver fibrosis. In conclusion, our study demonstrates that the delivery of ERA using SPIONs enhances the therapeutic efficacy of ERA in vivo. This approach holds promise as a theranostic strategy for the MRI-based diagnosis and treatment of liver fibrosis.
Collapse
Affiliation(s)
- Marit ten Hove
- Personalized Diagnostics and Therapeutics, Department of Bioengineering Technologies, Technical Medical Centre, Faculty of Science and Technology, University of Twente, Enschede, the Netherlands
| | - Andreas Smyris
- Personalized Diagnostics and Therapeutics, Department of Bioengineering Technologies, Technical Medical Centre, Faculty of Science and Technology, University of Twente, Enschede, the Netherlands
| | - Richell Booijink
- Personalized Diagnostics and Therapeutics, Department of Bioengineering Technologies, Technical Medical Centre, Faculty of Science and Technology, University of Twente, Enschede, the Netherlands
| | - Lydia Wachsmuth
- Clinic of Radiology, University Hospital Muenster, Muenster, Germany
| | - Uwe Hansen
- Institute for Musculoskeletal Medicine, University Hospital Muenster, Muenster, Germany
| | - Lejla Alic
- Department of Magnetic Detection and Imaging, Technical Medical Centre, Faculty of Science and Technology, University of Twente, Enschede, the Netherlands
| | - Cornelius Faber
- Clinic of Radiology, University Hospital Muenster, Muenster, Germany
| | - Carsten Hӧltke
- Clinic of Radiology, University Hospital Muenster, Muenster, Germany
| | - Ruchi Bansal
- Personalized Diagnostics and Therapeutics, Department of Bioengineering Technologies, Technical Medical Centre, Faculty of Science and Technology, University of Twente, Enschede, the Netherlands
| |
Collapse
|
2
|
Gandarias L, Gubieda AG, Gorni G, Mathon O, Olivi L, Abad-Díaz-de-Cerio A, Fdez-Gubieda ML, Muela A, García-Prieto A. Intracellular transformation and disposal mechanisms of magnetosomes in macrophages and cancer cells. Biotechnol J 2023; 18:e2300173. [PMID: 37337924 DOI: 10.1002/biot.202300173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2023] [Revised: 05/24/2023] [Accepted: 06/14/2023] [Indexed: 06/21/2023]
Abstract
Magnetosomes are magnetite nanoparticles biosynthesized by magnetotactic bacteria. Given their potential clinical applications for the diagnosis and treatment of cancer, it is essential to understand what becomes of them once they are within the body. With this aim, here we have followed the intracellular long-term fate of magnetosomes in two cell types: cancer cells (A549 cell line), because they are the actual target for the therapeutic activity of the magnetosomes, and macrophages (RAW 264.7 cell line), because of their role at capturing foreign agents. It is shown that cells dispose of magnetosomes using three mechanisms: splitting them into daughter cells, excreting them to the surrounding environment, and degrading them yielding less or non-magnetic iron products. A deeper insight into the degradation mechanisms by means of time-resolved X-ray absorption near-edge structure (XANES) spectroscopy has allowed us to follow the intracellular biotransformation of magnetosomes by identifying and quantifying the iron species occurring during the process. In both cell types there is a first oxidation of magnetite to maghemite and then, earlier in macrophages than in cancer cells, ferrihydrite starts to appear. Given that ferrihydrite is the iron mineral phase stored in the cores of ferritin proteins, this suggests that cells use the iron released from the degradation of magnetosomes to load ferritin. Comparison of both cellular types evidences that macrophages are more efficient at disposing of magnetosomes than cancer cells, attributed to their role in degrading external debris and in iron homeostasis.
Collapse
Affiliation(s)
- Lucía Gandarias
- Dpto. Inmunología, Microbiología y Parasitología, Universidad del País Vasco - UPV/EHU, Leioa, Spain
- Bioscience and Biotechnology Institute of Aix-Marseille (BIAM), UMR7265, Aix-Marseille Université, CNRS, CEA Cadarache, Saint-Paul-lez-Durance, France
| | - Alicia G Gubieda
- Dpto. Inmunología, Microbiología y Parasitología, Universidad del País Vasco - UPV/EHU, Leioa, Spain
| | - Giulio Gorni
- BL22-CLAESS Beamline, ALBA Synchrotron, Barcelona, Spain
- Institute of Optics (IO-CSIC), c/ Serrano 121, Madrid, Spain
| | | | - Luca Olivi
- XAFS Beamline, Elettra Sincrotrone, Trieste, Italy
| | - Ana Abad-Díaz-de-Cerio
- Dpto. Inmunología, Microbiología y Parasitología, Universidad del País Vasco - UPV/EHU, Leioa, Spain
| | - M Luisa Fdez-Gubieda
- Dpto. Electricidad y Electrónica, Universidad del País Vasco - UPV/EHU, Leioa, Spain
| | - Alicia Muela
- Dpto. Inmunología, Microbiología y Parasitología, Universidad del País Vasco - UPV/EHU, Leioa, Spain
| | - Ana García-Prieto
- Dpto. Física Aplicada, Universidad del País Vasco - UPV/EHU, Bilbao, Spain
| |
Collapse
|
3
|
Skidmore S, Barker RA. Challenges in the clinical advancement of cell therapies for Parkinson's disease. Nat Biomed Eng 2023; 7:370-386. [PMID: 36635420 PMCID: PMC7615223 DOI: 10.1038/s41551-022-00987-y] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2019] [Accepted: 11/04/2022] [Indexed: 01/14/2023]
Abstract
Cell therapies as potential treatments for Parkinson's disease first gained traction in the 1980s, owing to the clinical success of trials that used transplants of foetal midbrain dopaminergic tissue. However, the poor standardization of the tissue for grafting, and constraints on its availability and ethical use, have hindered this treatment strategy. Recent advances in stem-cell technologies and in the understanding of the development of dopaminergic neurons have enabled preclinical advancements of promising stem-cell therapies. To move these therapies to the clinic, appropriate levels of safety screening, as well as optimization of the cell products and the scalability of their manufacturing, will be required. In this Review, we discuss how challenges pertaining to cell sources, functional and safety testing, manufacturing and storage, and clinical-trial design are being addressed to advance the translational and clinical development of cell therapies for Parkinson's disease.
Collapse
Affiliation(s)
- Sophie Skidmore
- Wellcome and MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre Cambridge Biomedical Campus, Cambridge, UK
| | - Roger A Barker
- Wellcome and MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre Cambridge Biomedical Campus, Cambridge, UK.
- John van Geest Centre for Brain Repair, Department of Clinical Neuroscience, For vie Site, Cambridge, UK.
| |
Collapse
|
4
|
Hamdi M, Elmowafy E, Abdel-Bar HM, ElKashlan AM, Al-Jamal KT, Awad GAS. Hyaluronic acid-entecavir conjugates-core/lipid-shell nanohybrids for efficient macrophage uptake and hepatotropic prospects. Int J Biol Macromol 2022; 217:731-747. [PMID: 35841964 DOI: 10.1016/j.ijbiomac.2022.07.067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2022] [Revised: 07/07/2022] [Accepted: 07/08/2022] [Indexed: 11/05/2022]
Abstract
Drug covalently bound to polymers had formed, lately, platforms with great promise in drug delivery. These drug polymer conjugates (DPC) boosted drug loading and controlled medicine release with targeting ability. Herein, the ability of entecavir (E) conjugated to hyaluronic acid (HA) forming the core of vitamin E coated lipid nanohybrids (EE-HA LPH), to target Kupffer cells and hepatocyte had been proved. The drug was associated to HA with efficiency of 93.48 ± 3.14 % and nanohybrids loading of 22.02 ± 2.3 %. DiI labelled lipidic nanohybrids improved the macrophage uptake in J774 cells with a 21 day hepatocytes retention post intramuscular injection. Finally, in vivo biocompatibility and safety with respect to body weight, organs indices and histopathological alterations were demonstrated. Coating with vitamin E and conjugation of E to HA (a CD44 ligand), could give grounds for prospective application for vectored nano-platform in hepatitis B.
Collapse
Affiliation(s)
- Mohamed Hamdi
- Department of Pharmaceutics, Faculty of Pharmacy, University of Sadat City, Egypt
| | - Enas Elmowafy
- Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain Shams University, Egypt
| | - Hend Mohamed Abdel-Bar
- Department of Pharmaceutics, Faculty of Pharmacy, University of Sadat City, Egypt; Institute of Pharmaceutical Science, Faculty of Life Sciences & Medicine, King's College London, United Kingdom.
| | - Akram M ElKashlan
- Department of Biochemistry, Faculty of Pharmacy, University of Sadat City, Egypt
| | - Khuloud T Al-Jamal
- Institute of Pharmaceutical Science, Faculty of Life Sciences & Medicine, King's College London, United Kingdom
| | - Gehanne A S Awad
- Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain Shams University, Egypt
| |
Collapse
|
5
|
Exploiting the layer-by-layer nanoarchitectonics for the fabrication of polymer capsules: A toolbox to provide multifunctional properties to target complex pathologies. Adv Colloid Interface Sci 2022; 304:102680. [PMID: 35468354 DOI: 10.1016/j.cis.2022.102680] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2022] [Revised: 04/12/2022] [Accepted: 04/13/2022] [Indexed: 01/12/2023]
Abstract
Polymer capsules fabricated via the layer-by-layer (LbL) approach have attracted a great deal of attention for biomedical applications thanks to their tunable architecture. Compared to alternative methods, in which the precise control over the final properties of the systems is usually limited, the intrinsic versatility of the LbL approach allows the functionalization of all the constituents of the polymeric capsules following relatively simple protocols. In fact, the final properties of the capsules can be adjusted from the inner cavity to the outer layer through the polymeric shell, resulting in therapeutic, diagnostic, or theranostic (i.e., combination of therapeutic and diagnostic) agents that can be adapted to the particular characteristics of the patient and face the challenges encountered in complex pathologies. The biomedical industry demands novel biomaterials capable of targeting several mechanisms and/or cellular pathways simultaneously while being tracked by minimally invasive techniques, thus highlighting the need to shift from monofunctional to multifunctional polymer capsules. In the present review, those strategies that permit the advanced functionalization of polymer capsules are accordingly introduced. Each of the constituents of the capsule (i.e., cavity, multilayer membrane and outer layer) is thoroughly analyzed and a final overview of the combination of all the strategies toward the fabrication of multifunctional capsules is presented. Special emphasis is given to the potential biomedical applications of these multifunctional capsules, including particular examples of the performed in vitro and in vivo validation studies. Finally, the challenges in the fabrication process and the future perspective for their safe translation into the clinic are summarized.
Collapse
|
6
|
Curcio A, Van de Walle A, Péchoux C, Abou-Hassan A, Wilhelm C. In Vivo Assimilation of CuS, Iron Oxide and Iron Oxide@CuS Nanoparticles in Mice: A 6-Month Follow-Up Study. Pharmaceutics 2022; 14:179. [PMID: 35057074 PMCID: PMC8780448 DOI: 10.3390/pharmaceutics14010179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2021] [Revised: 01/05/2022] [Accepted: 01/11/2022] [Indexed: 11/19/2022] Open
Abstract
Nanoparticles (NPs) are at the leading edge of nanomedicine, and determining their biosafety remains a mandatory precondition for biomedical applications. Herein, we explore the bioassimilation of copper sulfide NPs reported as powerful photo-responsive anticancer therapeutic agents. The nanoparticles investigated present a hollow shell morphology, that can be left empty (CuS NPs) or be filled with an iron oxide flower-like core (iron oxide@CuS NPs), and are compared with the iron oxide nanoparticles only (iron oxide NPs). CuS, iron oxide@CuS and iron oxide NPs were injected in 6-week-old mice, at doses coherent with an antitumoral treatment. Cu and Fe were quantified in the liver, spleen, kidneys, and lungs over 6 months, including the control animals, thus providing endogenous Cu and Fe levels in the first months after animal birth. After intravenous NPs administration, 77.0 ± 3.9% of the mass of Cu injected, and 78.6 ± 3.8% of the mass of Fe, were detected in the liver. In the spleen, we found 3.3 ± 0.6% of the injected Cu and 3.8 ± 0.6% for the Fe. No negative impact was observed on organ weight, nor on Cu or Fe homeostasis in the long term. The mass of the two metals returned to the control values within three months, a result that was confirmed by transmission electron microscopy and histology images. This bioassimilation with no negative impact comforts the possible translation of these nanomaterials into clinical practice.
Collapse
Affiliation(s)
- Alberto Curcio
- Laboratoire Physico Chimie Curie, Institut Curie, CNRS, PSL Research University, 75005 Paris, France; (A.C.); (A.V.d.W.)
- Laboratoire Matière et Systèmes Complexes (MSC), UMR 7057, CNRS, University of Paris, 75205 Paris, France
| | - Aurore Van de Walle
- Laboratoire Physico Chimie Curie, Institut Curie, CNRS, PSL Research University, 75005 Paris, France; (A.C.); (A.V.d.W.)
- Laboratoire Matière et Systèmes Complexes (MSC), UMR 7057, CNRS, University of Paris, 75205 Paris, France
| | - Christine Péchoux
- INRAE, UMR 1313 GABI, MIMA2-Plateau de Microscopie Electronique, 78352 Jouy-en-Josas, France;
| | - Ali Abou-Hassan
- PHysico-Chimie des Electrolytes et Nanosystèmes InterfaciauX, PHENIX, CNRS, Sorbonne Université, 75005 Paris, France;
| | - Claire Wilhelm
- Laboratoire Physico Chimie Curie, Institut Curie, CNRS, PSL Research University, 75005 Paris, France; (A.C.); (A.V.d.W.)
- Laboratoire Matière et Systèmes Complexes (MSC), UMR 7057, CNRS, University of Paris, 75205 Paris, France
| |
Collapse
|
7
|
Chauhan A, Midha S, Kumar R, Meena R, Singh P, Jha SK, Kuanr BK. Rapid tumor inhibition via magnetic hyperthermia regulated by caspase 3 with time-dependent clearance of iron oxide nanoparticles. Biomater Sci 2021; 9:2972-2990. [PMID: 33635305 DOI: 10.1039/d0bm01705a] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
Among conventional cancer therapies, radio-frequency magnetic hyperthermia (MHT) has widely been investigated for use with magnetic nanoparticles (MNPs). However, the majority of in vivo biodistribution studies have tested very low MNP dosages (equivalent to magnetic resonance imaging (MRI) applications) to check for clearance rate; which is far below the clinical dose of MHT. Due to this poor validation in preclinical scenarios, quite a few MNPs already in clinical use were later discontinued, on grounds of unexpected clinical outcomes in terms of inflammation, and prolonged clearance in vivo. By exploiting an economical method of synthesis, we have developed chitosan-coated Fe3O4 nanoparticles with high heating efficiency performance. Their anti-tumor response was evaluated in an ectopic tumor model of C6 glioblastoma by MHT. The intratumoral injection of MNPs on days 1 and 7 resulted in rapid tumor inhibition rate of 69.4% within 8 days, with complete inhibition within 32 days, and no recurrence recorded over a 5-month follow-up. Notably, the MNP-mediated MHT therapy achieved the highest degree of therapeutic efficacy required for complete tumor ablation by combining controlled temperature range (<44 °C), reduced MNP dosage; much lower than in most reported studies, and AMF parameters (time of exposure and frequency) within the clinical safety limit. Periodic body weight measurements confirmed negligible adverse side effects in rats. The anti-tumor activity was validated by severe apoptosis (TUNEL, cleaved Caspase-3), reduced proliferation (Ki 67) and disrupted vasculature (CD 31) in the Fe3O4-MHT-treated group. Real-time gene expression of pro-inflammatory cytokines (IL-6, TNF-α, IL-1α, IL-1β) confirmed the intratumoral activation of IL-6, suggesting the role of immunomodulation in triggering the adaptive immune response for faster tumor regression in the treated group. In addition, the biodistribution and clearance rate of MNPs monitored using ICP-OES confirmed their time-dependent biodegradation via excretion (urine, feces), phagocytosis (liver) and circulatory system (blood), with negligible deposition in other major organs (kidney, heart, lungs). Although we could not show complete clearance of our MNPs within the time frame tested, future studies should focus on combining MHT with immunotherapy, and target tumors at a much-reduced iron dose, consequently improving in vivo clearance rate, and hence overcoming the limitations of MHT in clinical therapy.
Collapse
Affiliation(s)
- Anjali Chauhan
- Special Centre for Nanoscience, Jawaharlal Nehru University, New Delhi-110067, India. and School of Life Sciences, Jawaharlal Nehru University, New Delhi-110067, India
| | - Swati Midha
- Special Centre for Nanoscience, Jawaharlal Nehru University, New Delhi-110067, India. and UCL Division of Surgery & Interventional Science, University College London, London, UK
| | - Ravi Kumar
- Special Centre for Nanoscience, Jawaharlal Nehru University, New Delhi-110067, India.
| | - Ravindra Meena
- Special Centre for Nanoscience, Jawaharlal Nehru University, New Delhi-110067, India.
| | - Pooja Singh
- National Institute of Plant Genome research, New Delhi-110067, India
| | - Sushil K Jha
- School of Life Sciences, Jawaharlal Nehru University, New Delhi-110067, India
| | - Bijoy K Kuanr
- Special Centre for Nanoscience, Jawaharlal Nehru University, New Delhi-110067, India.
| |
Collapse
|
8
|
Encapsulation of manganese dioxide nanoparticles into layer-by-layer polymer capsules for the fabrication of antioxidant microreactors. MATERIALS SCIENCE & ENGINEERING. C, MATERIALS FOR BIOLOGICAL APPLICATIONS 2020; 117:111349. [DOI: 10.1016/j.msec.2020.111349] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/02/2020] [Revised: 07/24/2020] [Accepted: 08/02/2020] [Indexed: 12/22/2022]
|
9
|
Torras M, Moya C, Pasquevich GA, Roig A. Accurate iron quantification in colloids and nanocomposites by a simple UV-Vis protocol. Mikrochim Acta 2020; 187:488. [PMID: 32761453 DOI: 10.1007/s00604-020-04454-w] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2020] [Accepted: 07/14/2020] [Indexed: 10/23/2022]
Abstract
The selection and comparative study is reported of calibration curves to quantify iron by a simple UV-Vis protocol based on the formation of iron (III) chloride complexes. The reliability of each calibration curve was evaluated using statistical and analytical parameters. The robustness of each calibration curve using superparamagnetic iron oxide nanoparticles (SPIONs) of different sizes and surface functionalization is demonstrated . We have also evaluated the effect of the particle coating and estimated the minimum time to ensure the full oxidation of iron (II) to (III) in sample solutions. Results from UV-Vis are comparable with those obtained from ICP-OES and from other spectroscopic techniques to quantify the iron. We advocate the proposed protocol as a simple and non-expensive route to determine accurately the iron content in colloidal and nanocomposite iron-based materials. Graphical abstract.
Collapse
Affiliation(s)
- Miquel Torras
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Carrer dels Til·lers s/n Campus UAB, 08193, Bellaterra, Spain
| | - Carlos Moya
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Carrer dels Til·lers s/n Campus UAB, 08193, Bellaterra, Spain.
- École Polytechnique de Bruxelles, Université libre de Bruxelles (ULB), Avenue F.D. Roosevelt 50, 165/64, 1050, Brussels, Belgium.
| | - Gustavo A Pasquevich
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Carrer dels Til·lers s/n Campus UAB, 08193, Bellaterra, Spain
- Instituto de Física La Plata (IFLP-CONICET), Universidad Nacional de la Plata, Diagonal 113 entre 63 y 64, 1900, La Plata, Argentina
| | - Anna Roig
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Carrer dels Til·lers s/n Campus UAB, 08193, Bellaterra, Spain
| |
Collapse
|
10
|
Matter MT, Li J, Lese I, Schreiner C, Bernard L, Scholder O, Hubeli J, Keevend K, Tsolaki E, Bertero E, Bertazzo S, Zboray R, Olariu R, Constantinescu MA, Figi R, Herrmann IK. Multiscale Analysis of Metal Oxide Nanoparticles in Tissue: Insights into Biodistribution and Biotransformation. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2020; 7:2000912. [PMID: 32775166 PMCID: PMC7404155 DOI: 10.1002/advs.202000912] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/31/2020] [Revised: 04/22/2020] [Indexed: 05/05/2023]
Abstract
Metal oxide nanoparticles have emerged as exceptionally potent biomedical sensors and actuators due to their unique physicochemical features. Despite fascinating achievements, the current limited understanding of the molecular interplay between nanoparticles and the surrounding tissue remains a major obstacle in the rationalized development of nanomedicines, which is reflected in their poor clinical approval rate. This work reports on the nanoscopic characterization of inorganic nanoparticles in tissue by the example of complex metal oxide nanoparticle hybrids consisting of crystalline cerium oxide and the biodegradable ceramic bioglass. A validated analytical method based on semiquantitative X-ray fluorescence and inductively coupled plasma spectrometry is used to assess nanoparticle biodistribution following intravenous and topical application. Then, a correlative multiscale analytical cascade based on a combination of microscopy and spectroscopy techniques shows that the topically applied hybrid nanoparticles remain at the initial site and are preferentially taken up into macrophages, form apatite on their surface, and lead to increased accumulation of lipids in their surroundings. Taken together, this work displays how modern analytical techniques can be harnessed to gain unprecedented insights into the biodistribution and biotransformation of complex inorganic nanoparticles. Such nanoscopic characterization is imperative for the rationalized engineering of safe and efficacious nanoparticle-based systems.
Collapse
Affiliation(s)
- Martin T. Matter
- Particles‐Biology Interactions, Department of Materials Meet LifeSwiss Federal Laboratories for Materials Science and Technology (Empa)Lerchenfeldstrasse 5St. Gallen9014Switzerland
- Nanoparticle Systems Engineering LaboratoryInstitute of Process EngineeringDepartment of Mechanical and Process EngineeringETH ZurichSonneggstrasse 3Zurich8092Switzerland
| | - Jian‐Hao Li
- Particles‐Biology Interactions, Department of Materials Meet LifeSwiss Federal Laboratories for Materials Science and Technology (Empa)Lerchenfeldstrasse 5St. Gallen9014Switzerland
- Nanoparticle Systems Engineering LaboratoryInstitute of Process EngineeringDepartment of Mechanical and Process EngineeringETH ZurichSonneggstrasse 3Zurich8092Switzerland
| | - Ioana Lese
- Department of Plastic and Hand SurgeryUniversity Hospital Bern (Inselspital)University of BernBern3010Switzerland
| | - Claudia Schreiner
- Advanced Analytical TechnologiesSwiss Federal Laboratories for Materials Science and Technology (Empa)Uberlandstrasse 129Dubendorf8600Switzerland
| | - Laetitia Bernard
- Nanoscale MaterialsDepartment of Materials Meet LifeSwiss Federal Laboratories for Materials Science and Technology (Empa)Uberlandstrasse 129Dubendorf8600Switzerland
| | - Olivier Scholder
- Nanoscale MaterialsDepartment of Materials Meet LifeSwiss Federal Laboratories for Materials Science and Technology (Empa)Uberlandstrasse 129Dubendorf8600Switzerland
| | - Jasmin Hubeli
- Advanced Analytical TechnologiesSwiss Federal Laboratories for Materials Science and Technology (Empa)Uberlandstrasse 129Dubendorf8600Switzerland
| | - Kerda Keevend
- Particles‐Biology Interactions, Department of Materials Meet LifeSwiss Federal Laboratories for Materials Science and Technology (Empa)Lerchenfeldstrasse 5St. Gallen9014Switzerland
- Nanoparticle Systems Engineering LaboratoryInstitute of Process EngineeringDepartment of Mechanical and Process EngineeringETH ZurichSonneggstrasse 3Zurich8092Switzerland
| | - Elena Tsolaki
- Particles‐Biology Interactions, Department of Materials Meet LifeSwiss Federal Laboratories for Materials Science and Technology (Empa)Lerchenfeldstrasse 5St. Gallen9014Switzerland
- Nanoparticle Systems Engineering LaboratoryInstitute of Process EngineeringDepartment of Mechanical and Process EngineeringETH ZurichSonneggstrasse 3Zurich8092Switzerland
- Department of Medical Physics and Biomedical EngineeringUniversity College London (UCL)Malet Place Engineering BuildingLondonWC1E 6BTUK
| | - Enrico Bertero
- Mechanics of Materials and NanostructuresSwiss Federal Laboratories for Materials Science and Technology (Empa)Feuerwerkerstrasse 39Thun3602Switzerland
| | - Sergio Bertazzo
- Department of Medical Physics and Biomedical EngineeringUniversity College London (UCL)Malet Place Engineering BuildingLondonWC1E 6BTUK
| | - Robert Zboray
- Center for X‐ray AnalyticsSwiss Federal Laboratories for Materials Science and Technology (Empa)Uberlandstrasse 129Dubendorf8600Switzerland
| | - Radu Olariu
- Department of Plastic and Hand SurgeryUniversity Hospital Bern (Inselspital)University of BernBern3010Switzerland
| | - Mihai A. Constantinescu
- Department of Plastic and Hand SurgeryUniversity Hospital Bern (Inselspital)University of BernBern3010Switzerland
| | - Renato Figi
- Advanced Analytical TechnologiesSwiss Federal Laboratories for Materials Science and Technology (Empa)Uberlandstrasse 129Dubendorf8600Switzerland
| | - Inge K. Herrmann
- Particles‐Biology Interactions, Department of Materials Meet LifeSwiss Federal Laboratories for Materials Science and Technology (Empa)Lerchenfeldstrasse 5St. Gallen9014Switzerland
- Nanoparticle Systems Engineering LaboratoryInstitute of Process EngineeringDepartment of Mechanical and Process EngineeringETH ZurichSonneggstrasse 3Zurich8092Switzerland
| |
Collapse
|
11
|
Luther DC, Huang R, Jeon T, Zhang X, Lee YW, Nagaraj H, Rotello VM. Delivery of drugs, proteins, and nucleic acids using inorganic nanoparticles. Adv Drug Deliv Rev 2020; 156:188-213. [PMID: 32610061 PMCID: PMC8559718 DOI: 10.1016/j.addr.2020.06.020] [Citation(s) in RCA: 154] [Impact Index Per Article: 38.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2020] [Revised: 06/17/2020] [Accepted: 06/18/2020] [Indexed: 01/03/2023]
Abstract
Inorganic nanoparticles provide multipurpose platforms for a broad range of delivery applications. Intrinsic nanoscopic properties provide access to unique magnetic and optical properties. Equally importantly, the structural and functional diversity of gold, silica, iron oxide, and lanthanide-based nanocarriers provide unrivalled control of nanostructural properties for effective transport of therapeutic cargos, overcoming biobarriers on the cellular and organismal level. Taken together, inorganic nanoparticles provide a key addition to the arsenal of delivery vectors for fighting disease and improving human health.
Collapse
Affiliation(s)
- David C Luther
- Department of Chemistry, University of Massachusetts Amherst, 710 N. Pleasant St., Amherst, MA 01003, USA
| | - Rui Huang
- Department of Chemistry, University of Massachusetts Amherst, 710 N. Pleasant St., Amherst, MA 01003, USA
| | - Taewon Jeon
- Department of Chemistry, University of Massachusetts Amherst, 710 N. Pleasant St., Amherst, MA 01003, USA; Molecular and Cellular Biology Graduate Program, University of Massachusetts Amherst, 710 N. Pleasant St., Amherst, MA 01003, USA
| | - Xianzhi Zhang
- Department of Chemistry, University of Massachusetts Amherst, 710 N. Pleasant St., Amherst, MA 01003, USA
| | - Yi-Wei Lee
- Department of Chemistry, University of Massachusetts Amherst, 710 N. Pleasant St., Amherst, MA 01003, USA
| | - Harini Nagaraj
- Department of Chemistry, University of Massachusetts Amherst, 710 N. Pleasant St., Amherst, MA 01003, USA
| | - Vincent M Rotello
- Department of Chemistry, University of Massachusetts Amherst, 710 N. Pleasant St., Amherst, MA 01003, USA.
| |
Collapse
|
12
|
Patsula V, Horák D, Kučka J, Macková H, Lobaz V, Francová P, Herynek V, Heizer T, Páral P, Šefc L. Synthesis and modification of uniform PEG-neridronate-modified magnetic nanoparticles determines prolonged blood circulation and biodistribution in a mouse preclinical model. Sci Rep 2019; 9:10765. [PMID: 31341232 PMCID: PMC6656745 DOI: 10.1038/s41598-019-47262-w] [Citation(s) in RCA: 54] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2019] [Accepted: 07/05/2019] [Indexed: 12/19/2022] Open
Abstract
Magnetite (Fe3O4) nanoparticles with uniform sizes of 10, 20, and 31 nm were prepared by thermal decomposition of Fe(III) oleate or mandelate in a high-boiling point solvent (>320 °C). To render the particles with hydrophilic and antifouling properties, their surface was coated with a PEG-containing bisphosphonate anchoring group. The PEGylated particles were characterized by a range of physicochemical methods, including dynamic light scattering, transmission electron microscopy, thermogravimetric analysis, Fourier transform infrared spectroscopy, and magnetization measurements. As the particle size increased from 10 to 31 nm, the amount of PEG coating decreased from 28.5 to 9 wt.%. The PEG formed a dense brush-like shell on the particle surface, which prevented particles from aggregating in water and PBS (pH 7.4) and maximized the circulation time in vivo. Magnetic resonance relaxometry confirmed that the PEG-modified Fe3O4 nanoparticles had high relaxivity, which increased with increasing particle size. In the in vivo experiments in a mouse model, the particles provided visible contrast enhancement in the magnetic resonance images. Almost 70% of administrated 20-nm magnetic nanoparticles still circulated in the blood stream after four hours; however, their retention in the tumor was rather low, which was likely due to the antifouling properties of PEG.
Collapse
Affiliation(s)
- Vitalii Patsula
- Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 162 06, Prague 6, Czech Republic
| | - Daniel Horák
- Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 162 06, Prague 6, Czech Republic.
| | - Jan Kučka
- Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 162 06, Prague 6, Czech Republic
| | - Hana Macková
- Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 162 06, Prague 6, Czech Republic
| | - Volodymyr Lobaz
- Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 162 06, Prague 6, Czech Republic
| | - Pavla Francová
- Center of Advanced Preclinical Imaging, First Faculty of Medicine, Charles University, Salmovská 3, 120 00, Prague 2, Czech Republic
| | - Vít Herynek
- Center of Advanced Preclinical Imaging, First Faculty of Medicine, Charles University, Salmovská 3, 120 00, Prague 2, Czech Republic
| | - Tomáš Heizer
- Center of Advanced Preclinical Imaging, First Faculty of Medicine, Charles University, Salmovská 3, 120 00, Prague 2, Czech Republic
| | - Petr Páral
- Center of Advanced Preclinical Imaging, First Faculty of Medicine, Charles University, Salmovská 3, 120 00, Prague 2, Czech Republic
| | - Luděk Šefc
- Center of Advanced Preclinical Imaging, First Faculty of Medicine, Charles University, Salmovská 3, 120 00, Prague 2, Czech Republic
| |
Collapse
|